Print Page  Close Window

SEC Filings

10-Q
ACETO CORP filed this Form 10-Q on 11/03/2017
Entire Document
 << Previous Page | Next Page >>

 

 

RESULTS OF OPERATIONS

 

Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

 

   Net Sales by Segment
Three months ended September 30,
 
                         
   2017   2016   Comparison 2017
Over/(Under) 2016
 
       % of       % of   $   % 
Segment  Net sales   Total   Net sales   Total   Change   Change 
                         
Human Health  $106,015    57.2%  $47,889    37.4%  $58,126    121.4%
Pharmaceutical Ingredients   36,576    19.8    40,616    31.7    (4,040)   (9.9)
Performance Chemicals   42,664    23.0    39,513    30.9    3,151    8.0 
                               
Net sales  $185,255    100.0%  $128,018    100.0%  $57,237    44.7%

 

   Gross Profit by Segment
Three months ended September 30,
 
   2017   2016   Comparison 2017
Over/(Under) 2016
 
   Gross   % of   Gross   % of   $   % 
Segment  Profit   Sales   Profit   Sales   Change   Change 
                         
Human Health  $24,647    23.2%  $14,205    29.7%  $10,442    73.5%
Pharmaceutical Ingredients   5,840    16.0    6,954    17.1    (1,114)   (16.0)
Performance Chemicals   9,496    22.3    9,680    24.5    (184)   (1.9)
                               
Gross profit  $39,983    21.6%  $30,839    24.1%  $9,144    29.7%

 

Net Sales

 

Net sales increased $57,237, or 44.7%, to $185,255 for the three months ended September 30, 2017, compared with $128,018 for the prior period. We reported sales increases in our Human Health and Performance Chemicals segments and a decrease in our Pharmaceutical Ingredients segment.

 

Human Health

 

Net sales for the Human Health segment increased by $58,126 for the three months ended September 30, 2017, to $106,015, which represents a 121.4% increase over net sales of $47,889 for the prior period. The primary reason for the increase is due to the acquisition of certain products and related assets of Citron and Lucid. Sales from the product acquisition of $55,130 are included in the three months ended September 30, 2017.

 

 24 
 << Previous Page | Next Page >>